Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT00030160
Eligibility Criteria:
Eligible participants will include women between the ages of 25 and 44, BMI between 25 and 35 (inclusive).
Other inclusion/exclusion criteria:
1. Weight stable (\<5% body weight change over past year)
2. No medical conditions or medications that would prohibit participation in an exercise program or would negatively impact our ability to test our primary aims (e.g. fibromyalgia, chronic fatigue syndrome, metabolic disorders, recent cardiovascular event, orthopedic limitations, any drug expected to impact body weight, psychiatric disorders requiring anti-psychotic drugs)
3. Uncontrolled hypertension (systolic blood pressure over 160 and/or diastolic blood pressure over 99)
4. No history of cancer within the past 5 years, excepting non-melanoma skin cancers
5. Not currently or recently (past 6 months) pregnant
6. Not planning to become pregnant during the study period
7. Not currently or recently (past 2 months) lactating
8. No history of physician diagnosed menstrual irregularities or significant gynecologic conditions (e.g. fibroids, endometriosis)
9. Pre-menopausal
10. Current non-smokers (for at least the past 2 years)
11. Sedentary to modestly physically active (up to 3 sessions weekly of physical activity of no greater intensity than brisk walking) with no history of strength training within the past 6 months
12. Not planning to move away from the Twin Cities area over the next 2 years
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
25 Years
Maximum Age:
44 Years
Study:
NCT00030160
Study Brief:
Protocol Section:
NCT00030160